Efficacy of a Deep Cleansing Gel Containing 2% Salicylic Acid, 0.2% Zinc Gluconate and 0.05% Lipohydroxy Acid in the Management of Mild to Moderate Facial Acne

ASSESSMENT OF CLINICAL, INSTRUMENTAL AND NOTICED EFICACY BY SUBJECTS OF A COSMETIC PRODUCT 12.0417.01.090 UNDER NORMAL CONDITIONS OF USE Study With Dermatological Follow-up Including Instrumental Measurements

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05779085

Enrollment

Registered

2023-03-22

Start date

2013-04-08

Completion date

2013-07-22

Last updated

2023-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris on the Face

Brief summary

A clinical study with 56 healthy subjects (both sexes) aged between 13 to 25 years old. Subjects enrolled had a minimum of 5 inflammatory lesions (papules, nodules and pustules) and 10 non-inflammatory lesions (open and closed comedones), determined by dermatologist. The clinical evaluation considered in oiliness, shininess and global aspect of the skin too. Instrumental assessment of oiliness and shininess was performed, respectively, by Sebumeter and Sebutape. IThe tested cleanser was used twice daily (morning and evening) during 28 days.

Interventions

OTHERDermocosmetic

Use of daily cleanser to treat facial acne

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

13 Years to 26 Years

Inclusion criteria

* subjects aged 13-25 years * mild to moderate acne on the face * signed informed consent

Exclusion criteria

* subjects below 13 years and above 26 years * severe acne on the face

Design outcomes

Primary

Measure	Time frame	Description
Global lesion count	baseline	using GEA scale
Closed comedones	baseline	count
papules	baseline	count
skin oiliness	baseline	instrumental measurement Sebumeter
skin sebutape	baseline	instrumental measurement Sebumeter
subject satisfaction	Day 28	questionnaire

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026